Related Experiment Video
Updated: Sep 23, 2025

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
The changes of AHI after long-term CPAP in patients with comorbid OSA and cardiovascular disease
Yilu Cheng1, Qiong Ou2, Baixin Chen1
1Sleep Center, Department of Pulmonary and Critical Care Medicine, Guangdong Provincial People's Hospital/Guangdong Academy of Medical Sciences/Guangdong Provincial Geriatrics Institute, Guangzhou, 510080, China.
Insights
Long-term continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea (OSA) did not significantly alter overall disease severity. However, CPAP showed variable effects based on OSA severity, improving metrics in moderate and severe cases.
Area of Science:
- Sleep Medicine
- Cardiovascular Health
- Respiratory Medicine
Background:
- Obstructive sleep apnea (OSA) is a common sleep disorder associated with cardiovascular and cerebrovascular diseases.
- Continuous positive airway pressure (CPAP) is a primary treatment for OSA, aiming to improve sleep quality and reduce health risks.
- The long-term efficacy of CPAP in improving OSA disease severity, particularly in patients with existing cardiovascular conditions, requires further evaluation.
Purpose of the Study:
- To assess the long-term impact of continuous positive airway pressure (CPAP) on the disease severity of obstructive sleep apnea (OSA).
- To investigate whether CPAP treatment influences key indicators of OSA severity over an extended period.
- To explore potential differential effects of CPAP based on the baseline severity of OSA.
Main Methods:
- Analysis of data from the Sleep Apnea and Cardiovascular Events (SAVE) study, involving patients aged 45-75 with cardiac or cerebrovascular disease.
- Randomization of participants to either CPAP plus standard care or standard care alone, with follow-up lasting several years.
- Home sleep apnea testing (HSAT) conducted at baseline and study conclusion to measure changes in apnea-hypopnea index (AHI) and other OSA indicators.
Main Results:
- While the apnea-hypopnea index (AHI) decreased in both CPAP and usual care groups, there was no significant difference between them.
- An improvement in the lowest oxygen saturation (nadir SpO2) was observed in the CPAP group but not the usual care group.
- Subgroup analysis indicated that CPAP improved AHI in moderate OSA and nadir SpO2 in severe OSA.
Conclusions:
- Long-term CPAP use did not lead to clinically significant overall improvements in AHI or oxygen desaturation index (ODI) in this patient cohort.
- The study highlights that the benefits of CPAP may be stratified by OSA severity, with notable improvements observed in specific subgroups.
- Further research is warranted to understand the nuanced effects of CPAP on OSA severity and associated cardiovascular outcomes.
Purpose:
To evaluate the effect of long-term continuous positive airway pressure (CPAP) treatment on disease severity of obstructive sleep apnea (OSA).
Methods:
We analyzed results from the Sleep Apnea and Cardiovascular Events (SAVE) study involving participants recruited at the Guangdong Provincial People's Hospital, China. Participants were aged 45-75 years with a history of cardiac or cerebrovascular disease. OSA was confirmed by home sleep apnea testing (HSAT). Participants were randomized to receive CPAP plus standard cardiovascular care (CPAP group) or standard care alone (UC group) and followed for several years. At the study conclusion, surviving participants were invited to repeat HSAT. Changes in OSA indicators were compared by independent samples t-tests and subgroup analysis was implied among groups stratified by OSA severity.
Results:
One hundred two adults were recruited (51 per group) and followed for 48.0 ± 14.5 months. Daily CPAP usage in the CPAP group was 4.1 ± 1.9 h. AHI decreased from baseline to end-of-study in both CPAP and UC groups (- 5.0 (- 12.5,2.0), P = 0.000; - 4.0 (- 12.5,1.5), P = 0.007, respectively), with no between-group difference (P = 0.453). An improvement in nadir SpO2 showed from baseline to end-of-study in the CPAP but not UC group (2.3% ± 6.1%, P = 0.011 and - 0.7% ± 7.6%, P = 0.511, respectively; between-group difference P = 0.032). Subgroup analysis shows that CPAP could improve AHI in patients with moderate OSA (- 8.0 (- 11.8, - 2.8) in CPAP group, - 2.0 (- 0.8,6.0) in UC group, P = 0.022) and improve nadir SpO2 in patients with severe OSA (5.0 (- 0.8, - 0.8,7.0) in CPAP group, 0.0 (- 8.5,2.5) in UC group, P = 0.032).
Conclusion:
Long-term CPAP use did not result in clinically significant changes in AHI or ODI overall but showed variable effects stratified by OSA severity.
Clinical Trial Registration:
Registry: Clinical Trials.gov, title: Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease (SAVE), URL: www.
Clinicaltrials:
gov , identifier: NCT00738179.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Respiratory Volumes and Capacities I
Hyperpnea and Hyperventilation
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration...
Heart Failure VI: Adjunct Therapies
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...

